Drawing for ZEVIPTO

USPTO serial 79386352

ZEVIPTO

Reviewed by CopyMark Law Group

Reg. 7691329Status 700Registered
Filing date
Status date
Registration date
Feb 18, 2025
Examiner
CARLYLE, SHAUNIA P
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ZEVIPTO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC3724 Benson DriveRaleigh, NC 27609United States

Goods and services

ClassDescriptionStatusFirst use
005Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma; all of the above with the exception of pharmaceuticals for the prevention and treatment of central nervous system diseases and disordersACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 19, 2025FINVFINAL DECISION TRANSACTION PROCESSED BY IB
Sep 1, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB
Sep 1, 2025FIMPFINAL DISPOSITION PROCESSED
Jun 13, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 27, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 27, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 18, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 18, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 18, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 31, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 31, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 25, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 3, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Nov 6, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Nov 6, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 6, 2024ALIEASSIGNED TO LIE
Aug 15, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 15, 2024NREVNOTICE OF REVIVAL - E-MAILED
Aug 15, 2024PETGPETITION TO REVIVE-GRANTED
Aug 15, 2024PROATEAS PETITION TO REVIVE RECEIVED
Mar 5, 2024RFNTREFUSAL PROCESSED BY IB
Feb 13, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 13, 2024RFRRREFUSAL PROCESSED BY MPU
Feb 5, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 5, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Feb 5, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 5, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 5, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 5, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 25, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 24, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 23, 2024MAFRAPPLICATION FILING RECEIPT MAILED
Jan 18, 2024DOCKASSIGNED TO EXAMINER
Jan 17, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 29, 2023LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 28, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance